3 reasons why Dr Phil better be careful about raising interest rates & could stocks slide tomorrow?

Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Anthony Doyle from Firetrail Investments and Paul Rickard is joined by Angus Moore from Proptrack.

Dr Ross explains whether immunotherapy could be the new approach that could lead to an effective treatment for various types of cancer.

Paul Rickard is joined by Rudi Filapek-Vandyck of FNArena, Raymond Chan of Morgans, and Anna Porter from Suburbanite.

US inflation disappoints & Wall Street tanks + Star Entertainment: 'Unfit to hold casino license'.

Paul Rickard is joined by Michael Wayne of Medallion Financial, Adam Dawes of Shaw and Partners, and Ron Shamgar of Tamim Asset Management.

Dr Ross has a look at whether a high dose of vitamin E can actually lead to death, as some studies show.

Paul Rickard is joined by Marcus Bogdan of Blackmore Capital, Eleanor Creagh of PropTrack, and Michael Knox of Morgans.

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Paul Rickard shares his thoughts on the market and is joined by Jun Bei Liu of Tribeca Investment Partners, and Diana Mousina of AMP Capital.

In blanket terms, dementia is the chronic loss of functional nerve cells in the central nervous system. But just how many different variations are there?

Paul Rickard shares his thoughts on the market and is then joined by Shane Oliver of AMP Capital, and Arjun Paliwal of InvestorKit.